Page 1262 - Basic _ Clinical Pharmacology ( PDFDrive )

1248 Index

Valproic acid, 529t calcitonin gene-related peptide, Vasomera, 313
bipolar disorder treated with, 528, 529t 314–315 Vasopressin (antidiuretic hormone, ADH),
migraine headache prophylaxis using, endothelins, 311–312 268, 308, 681–682, 684t
291 kinins, 306–307 blood pressure affected by, 175
myoclonic seizures treated with, 430 natriuretic peptides, 308–309 diuresis using, 268
seizures treated with, 426f, 426–427, neuropeptide Y, 315–316 structures of, 681f
430, 433t, 436t neurotensin, 314 variceal hemorrhage treated
Valsartan, 310 preparations available, 318t with, 1114
heart failure treated with, 224t substance P, 313–314 on vasoactive peptides, 317t
hypertension treated with, 189 urotensin, 316 Vasopressin receptor, 308
on renin-angiotensin system, 305 vasoactive intestinal peptide, Vasopressin receptor agonists, 268, 308,
on vasoactive peptides, 316t 312–313 317t, 681–682, 684t
Vancomycin, 803t, 807–809, 812t vasopressin, 308 preparations available, 685t
“Vaping,” 121 Vasodilators, angina pectoris treated with, on vasoactive peptides, 317t
Vardenafil, 200b 194–210, 209t–210t. See also Vasopressin receptor antagonists
Varenicline, 122t specific drug description of, 268, 273t, 308,
nicotine abuse treated with, allopurinol, 207 682, 684t
584, 588t beta blockers, 206–207, 210t preparations available, 318t,
smoking cessation using, 121 calcium channel blockers, 202–206 685t
Variant, 75t clinical pharmacology of Vasospastic angina, 194, 208
Variant angina, 194 angina of effort, 208, 208f, 209t Vecuronium. See also Neuromuscular
ergot alkaloids for diagnosis of, 295 nitrates alone vs. with beta or calcium blocking drugs
nitrate effects in, 201 channel blockers, 208, 209t properties of, 478t, 489t
Variceal hemorrhage drugs principles of, 207 structure of, 477f
beta-receptor blocking drugs, 1114 unstable angina and acute coronary Vedolizumab, 995, 1112
preparations available, 1117t syndromes, 208–209 Vehicles
somatostatin and octreotide, 1114, vasospastic angina, 208 dermatologic, 1068–1086
1116t with coronary artery disease and drug, 7
vasopressin and terlipressin, 1114 hyperlipidemia, 194, 211 Velpatasvir, 889
Varicella vaccine, 1178t drug action in, 196–197 Vemurafenib, 975
Varicella-zoster immune globulin, fasudil, 207 Venlafaxine, 537, 540t, 542t, 549t.
1181t ivabradine, 207 See also Serotonin-norepinephrine
Varicella-zoster virus (VZV) agents, newer drugs, 207t reuptake inhibitors (SNRIs)
864–867 nitrates and nitrites, 197–202, 202t, dosing of, 546t
acyclovir, 865t, 866, 866f 210t poisoning with, 1042
docosanol, 865t, 867 nitro-vasodilators, other, 202 Venous thrombosis, 735
famciclovir, 865t, 867 pFOX inhibitors, 207 Ventilation, alveolar, 443–444, 444f
penciclovir, 865t, 866f, 867 preparations available, 211t Ventilation control, neuromuscular blockers
trifluridine, 865t, 866f, 867 ranolazine, 207 for, 485
valacyclovir, 865t, 866–867 special, 206b Ventral tegmental area (VTA), in addiction,
valomaciclovir, 867 Vasodilators, nitric oxide as, 342 576, 576f, 579b
varicella vaccine, 1178t Vasodilators, for heart failure, 220, 225t Ventricular fibrillation, 236f
varicella-zoster immune globulin, acute, 224 Ventricular tachycardia
1181t chronic, 222 ECG of, 236f
Vascular endothelial growth factor (VEGF), Vasodilators, hypertension treated with, polymorphic, in torsades de pointes with
968 178f, 179t, 184–187, long QT syndrome, 233f, 234b,
Vascular smooth muscles, 198–199 191t, 192t 237f
Vascular tone, 195t, 195–196, 196f, 197f calcium channel blockers, 179t, Verapamil. See also Calcium channel
Vasculitis (type III) drug reactions, 186–187, 193t blockers
999–1000 diazoxide, 186, 192t angina pectoris treated with, 202–206,
Vasoactive intestinal peptide agonists, direct, 176 203t, 210t. See also Calcium
317t fenoldopam, 186, 192t channel blockers, angina pectoris
Vasoactive intestinal peptide (VIP), 92t, hydralazine, 179t, 184–185 treated with
312–313 mechanisms and sites of action of, 184, arrhythmia treated with, 239t, 240t,
Vasoactive peptides, 300–318, 317t 184t 245–246, 251t
adrenomedullin, 315 minoxidil, 179t, 185 case study on, 20, 40
angiotensin, 300–303 preparations available, 193t hypertension treated with, 179t, 187,
angiotensin II, 303–304 sodium nitroprusside, 185–186, 192t 191t